<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>米内网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-23T16:31:02+08:00</updated>
  <subtitle>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>又一家四川药企将上市！拿下16个首仿，10个1类新药抢眼，4大吸入剂抢首家</title>
    <updated>2020-12-23T16:00:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/fbKzuqssPPIAKvUpqLL0kg</id>
    <link href="https://mp.weixin.qq.com/s/fbKzuqssPPIAKvUpqLL0kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】逐鹿30亿大市场！4年复合增速280%，过亿产品崛起</title>
    <updated>2020-12-23T16:00:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/ZC3qE1ZGWCRC-ubXPOy8JQ</id>
    <link href="https://mp.weixin.qq.com/s/ZC3qE1ZGWCRC-ubXPOy8JQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】注射剂企业发威！入局超25亿大品种，10个新品来袭</title>
    <updated>2020-12-23T16:00:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/ZyJ5Uynhh5KQyB6SHLypSg</id>
    <link href="https://mp.weixin.qq.com/s/ZyJ5Uynhh5KQyB6SHLypSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【聚焦】2款国产创新药将获批！24个1类新药首次报产，豪森、华海......</title>
    <updated>2020-12-23T16:00:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/ZCCO65Zbqvn4lRS1Or-bwQ</id>
    <link href="https://mp.weixin.qq.com/s/ZCCO65Zbqvn4lRS1Or-bwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中成药贴膏剂零售TOP20排位生变！奇正、羚锐……10个独家产品“霸屏”，9个品牌销售过亿</title>
    <updated>2020-12-22T17:18:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/JAoLhAs9b610H4h4QP1z1Q</id>
    <link href="https://mp.weixin.qq.com/s/JAoLhAs9b610H4h4QP1z1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】东阳光药首个1类新药获批上市，今年7大品种已在路上</title>
    <updated>2020-12-22T17:18:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/sEu_7psaqUWqC8w9kl-fKQ</id>
    <link href="https://mp.weixin.qq.com/s/sEu_7psaqUWqC8w9kl-fKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【审评】扬子江瞄准超10亿抗癌药！阿斯利康八成市场再受冲击</title>
    <updated>2020-12-22T17:18:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/JjI15HyyfTQgxzQq6qsYQg</id>
    <link href="https://mp.weixin.qq.com/s/JjI15HyyfTQgxzQq6qsYQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【获批】30亿注射剂大品种！正大天晴又拿下首家过评</title>
    <updated>2020-12-22T17:18:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/t8TVmMHAKoNZXnO9Rgvayg</id>
    <link href="https://mp.weixin.qq.com/s/t8TVmMHAKoNZXnO9Rgvayg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>$50亿抗癌药首仿定了！齐鲁今年17个高端仿制药登场，集采大赢家正在备战</title>
    <updated>2020-12-21T16:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/lZ5oEl2r-H9wv-y_0gkRbg</id>
    <link href="https://mp.weixin.qq.com/s/lZ5oEl2r-H9wv-y_0gkRbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】海思科抢恒瑞市场！暴涨153%的抗血栓注射剂批了</title>
    <updated>2020-12-21T16:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/nSTrBxhp4E0XLDwNerNE_g</id>
    <link href="https://mp.weixin.qq.com/s/nSTrBxhp4E0XLDwNerNE_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】再次赶超人福拿下首家！恩华神经系统过评产品达6个</title>
    <updated>2020-12-21T16:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/uLKQyC1N0dGaJzXRqDKF_g</id>
    <link href="https://mp.weixin.qq.com/s/uLKQyC1N0dGaJzXRqDKF_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【热议】西奥罗尼大突破！微芯生物多个1类新药来袭</title>
    <updated>2020-12-21T16:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/RPpvpGCFztQvDk7q7k21QA</id>
    <link href="https://mp.weixin.qq.com/s/RPpvpGCFztQvDk7q7k21QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴发威了！35款1类新药霸屏，16个品种冲刺首仿，PD-1/L1等创新药步入收获期</title>
    <updated>2020-12-20T08:01:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/UIckHQJ5zhL5MDF7YOXGnA</id>
    <link href="https://mp.weixin.qq.com/s/UIckHQJ5zhL5MDF7YOXGnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药股“一哥”冲击6000亿市值，7个注射剂被点名调查，第四批集采已有企业发布降价预警</title>
    <updated>2020-12-19T08:02:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/joWVExIdM8tp2BF6AsuyTw</id>
    <link href="https://mp.weixin.qq.com/s/joWVExIdM8tp2BF6AsuyTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>毛利率超90%、冲击千亿市值……今年超40家药企“扎堆”上市！最赚钱的竟是它</title>
    <updated>2020-12-18T17:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/97avAYWItpDAFd4KhmV7vQ</id>
    <link href="https://mp.weixin.qq.com/s/97avAYWItpDAFd4KhmV7vQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【获批】对飚正大天晴、司太立！30亿造影剂，扬子江全规格过评</title>
    <updated>2020-12-18T17:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/ji9r__BAm2isWfIECIxUww</id>
    <link href="https://mp.weixin.qq.com/s/ji9r__BAm2isWfIECIxUww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【关注】恒瑞15亿注射剂迎“劲敌”！国药集团入局</title>
    <updated>2020-12-18T17:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/I7TTiZpmWCAuU-99gZVi1Q</id>
    <link href="https://mp.weixin.qq.com/s/I7TTiZpmWCAuU-99gZVi1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【审评】四川药企冲击超10亿吸入剂，原研药9成市场岌岌可危？</title>
    <updated>2020-12-18T17:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/QskOSAmst0C4BKyW7aUM2Q</id>
    <link href="https://mp.weixin.qq.com/s/QskOSAmst0C4BKyW7aUM2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光药大丰收！拿下14个重磅品种，“猛攻”600亿糖尿病市场，首个1类新药将获批</title>
    <updated>2020-12-17T16:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/oA1W_WkGlyqOlY6Exb0e-Q</id>
    <link href="https://mp.weixin.qq.com/s/oA1W_WkGlyqOlY6Exb0e-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】汇宇紫杉醇注射液将获批，超75亿市场生变</title>
    <updated>2020-12-17T16:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/q7dFvErnBeVojHNiTTKfeQ</id>
    <link href="https://mp.weixin.qq.com/s/q7dFvErnBeVojHNiTTKfeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>